Antigen Conjugation Articles & Analysis: Older
3 articles found
Antibody drug conjugates (ADCs) are a new class of biopharmaceuticals that use monoclonal antibodies to target tumor cells to deliver potent cytotoxic drugs. ...
Many strategies are being tested to solve this issue, including creating bi- or tri-specific CARs to recognize multiple tumor antigens simultaneously, or conjugating CAR T cells with other drugs. Nevertheless, CAR T cell therapy still shows much promise, and is a highly researched field. ...
The researchers expose us to a radically different way of thinking in this article: instead of working on T cells, they focus on changing cancer cell antigens. They employed antibodies to deliver viral antigens to the tumor location and trigger virus-specific T lymphocytes to target cancer cells, destroying them. ...